PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 200

Sponsor: Centre Hospitalier Universitaire de Liege

Summary

This prospective study will examine eosinophils in various biological materials to compare the detection in those materials and ascertain the prognostic and predictive role of eosinophils in untreated non-small cell lung cancer patient.

Eligibility Criteria

Inclusion Criteria:o All stages of NSCLCStage III-IV NSCLC eligible for ICI treatment18 years or older; non pregnant womenin stage III-IV: no previous ICI and before ICI (mono- or combination therapy) initiationSigned informed consentClinical, biological and radiological evaluation at the CHU de Liège for at least 6 months following treatment initiationExclusion Criteria:Probable noncompliance with the follow-up requirements of the study (psychiatric condition, socio-economic factors)Inclusion in a clinical study contraindicating the enrolment in the PROTEON study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05602259). StuddyBuddy aggregates publicly available trial information.